Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Histopathology|November 1, 2011
The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray studyGuy Lahat, Pingyu Zhang, Quan-Sheng Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic targetZeming Jin, Guy Lahat, Borys Korchin, et al.
Plos One|April 27, 2010
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesGuy Lahat, Quan-Sheng Zhu, Kai-Lieh Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcomaGonzalo Lopez, Juehui Liu, Wenhong Ren, et al.
Molecular Cancer Therapeutics|May 22, 2007
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulationJonathan A F Hannay, Juehui Liu, Quan-Sheng Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2011
Combining EGFR and mTOR blockade for the treatment of epithelioid sarcomaXianbiao Xie, Markus P H Ghadimi, Eric D Young, et al.
Molecular Cancer Therapeutics|May 7, 2009
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumorChangye Y Zou, Kerrington D Smith, Quan-Sheng Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2011
Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumorsKeila E Torres, Quan-Sheng Zhu, Katelynn Bill, et al.
Pageof 2